Veeva Systems’ Post

Transcript

Novo Nordisk, we have a broad history of the last hundred years, focusing on diabetes, and also obesity. And I think we have a lot of institutional knowledge from that standpoint. What I think a lot of people don't know is we also focus on some rare diseases like hemophilia, human growth hormone, and we're breaking into all kinds of other areas. There's two big factors that we use to make those decisions. One was innovation. We want to make sure as we move into our next one hundred years that we have software that's cutting edge, moving into the future, and allow us to be able to take advantage of what we're going to need to have great customer interactions. We also wanted flexibility. We have to be rock solid when it comes to our diabetes and our obesity. We know that really well. But as we move into new disease states, we want that software to be flexible because different customers, different ways that they may want to use things. Maybe it's more of account planning. Maybe it's pharmacy access. I think those two things are really the biggest factors that allowed us to make a decision. When we we thought about what we want to do, we took three things into consideration. One was partnership. Veeva is a great partner. From every single person we work with, it's an intimate relationship, A relationship that people care, and that's what a true partnership is about. Your goals and our goals meet together and they intersect and they work. The second is about products. Products that are flexible. Products that have innovation in it. Products that aren't sitting and waiting. I think the last part is vision, and vision has to do with where are we going and where do we want to go, but also knowing where we can meet together. And I think that those three things for Veeva and for Novo Nordisk work well together. We want to make sure that we're aligned for right now, but also into the future. We don't want to be behind the curve. Technology and customers, disease states, everything is changing at a pace that's much more rapid than it was 30 or 40 years ago. And I think that if you want to be able to stay ahead of the curve, if you want to be able to meet the needs of your customers, and meet the needs of what patients need, you've got to have software that's ahead of the curve. innovative and thoughtful and a good partner and do good for the world.